Annual SG&A
$28.21 M
-$12.52 M-30.73%
31 December 2023
Summary:
Talis Biomedical annual selling, general & administrative expenses is currently $28.21 million, with the most recent change of -$12.52 million (-30.73%) on 31 December 2023. During the last 3 years, it has risen by +$15.11 million (+115.32%). TLIS annual SG&A is now -33.49% below its all-time high of $42.42 million, reached on 31 December 2021.TLIS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$7.98 M
-$3.67 M-31.53%
30 June 2024
Summary:
Talis Biomedical quarterly selling, general & administrative expenses is currently $7.98 million, with the most recent change of -$3.67 million (-31.53%) on 30 June 2024. Over the past year, it has dropped by -$826.00 thousand (-9.38%). TLIS quarterly SG&A is now -37.64% below its all-time high of $12.79 million, reached on 30 September 2021.TLIS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.18 B
-$51.03 M-2.40%
30 June 2024
Summary:
Talis Biomedical TTM selling, general & administrative expenses is currently -$2.18 billion, with the most recent change of -$51.03 million (-2.40%) on 30 June 2024. Over the past year, it has dropped by -$2.21 billion (-6830.75%). TLIS TTM SG&A is now -2567.41% below its all-time high of $47.02 million, reached on 31 March 2022.TLIS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLIS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.7% | -9.4% | -6830.8% |
| 3 y3 years | +115.3% | -37.6% | -6260.6% |
| 5 y5 years | +419.4% | - | - |
TLIS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -33.5% | +115.3% | -37.6% | +24.7% | -109.7% | at low |
| 5 y | 5 years | -33.5% | +419.4% | -37.6% | +352.2% | -2567.4% | at low |
| alltime | all time | -33.5% | +419.4% | -37.6% | +352.2% | -2567.4% | at low |
Talis Biomedical Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $7.98 M(-31.5%) | $35.03 M(+4.7%) |
| Mar 2024 | - | $11.65 M(+76.5%) | $33.47 M(+18.6%) |
| Dec 2023 | $28.21 M(-30.7%) | $6.60 M(-25.0%) | $28.21 M(-12.9%) |
| Sept 2023 | - | $8.80 M(+37.3%) | $32.41 M(-0.1%) |
| June 2023 | - | $6.41 M(+0.2%) | $32.43 M(-7.9%) |
| Mar 2023 | - | $6.40 M(-40.7%) | $35.20 M(-13.6%) |
| Dec 2022 | $40.73 M(-4.0%) | $10.80 M(+22.3%) | $40.73 M(-3.6%) |
| Sept 2022 | - | $8.82 M(-3.8%) | $42.25 M(-8.6%) |
| June 2022 | - | $9.18 M(-23.1%) | $46.22 M(-1.7%) |
| Mar 2022 | - | $11.93 M(-3.1%) | $47.02 M(+10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $42.42 M(+223.7%) | $12.32 M(-3.7%) | $42.42 M(+19.8%) |
| Sept 2021 | - | $12.79 M(+28.1%) | $35.41 M(+37.9%) |
| June 2021 | - | $9.98 M(+36.2%) | $25.67 M(+39.9%) |
| Mar 2021 | - | $7.33 M(+38.1%) | $18.35 M(+40.0%) |
| Dec 2020 | $13.10 M(+90.9%) | $5.30 M(+73.5%) | $13.10 M(+37.0%) |
| Sept 2020 | - | $3.06 M(+15.0%) | $9.56 M(+47.0%) |
| June 2020 | - | $2.66 M(+27.9%) | $6.50 M(+69.2%) |
| Mar 2020 | - | $2.08 M(+17.9%) | $3.84 M(+117.9%) |
| Dec 2019 | $6.86 M(+26.4%) | $1.76 M | $1.76 M |
| Dec 2018 | $5.43 M | - | - |
FAQ
- What is Talis Biomedical annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Talis Biomedical?
- What is Talis Biomedical annual SG&A year-on-year change?
- What is Talis Biomedical quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Talis Biomedical?
- What is Talis Biomedical quarterly SG&A year-on-year change?
- What is Talis Biomedical TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Talis Biomedical?
- What is Talis Biomedical TTM SG&A year-on-year change?
What is Talis Biomedical annual selling, general & administrative expenses?
The current annual SG&A of TLIS is $28.21 M
What is the all time high annual SG&A for Talis Biomedical?
Talis Biomedical all-time high annual selling, general & administrative expenses is $42.42 M
What is Talis Biomedical annual SG&A year-on-year change?
Over the past year, TLIS annual selling, general & administrative expenses has changed by -$12.52 M (-30.73%)
What is Talis Biomedical quarterly selling, general & administrative expenses?
The current quarterly SG&A of TLIS is $7.98 M
What is the all time high quarterly SG&A for Talis Biomedical?
Talis Biomedical all-time high quarterly selling, general & administrative expenses is $12.79 M
What is Talis Biomedical quarterly SG&A year-on-year change?
Over the past year, TLIS quarterly selling, general & administrative expenses has changed by -$826.00 K (-9.38%)
What is Talis Biomedical TTM selling, general & administrative expenses?
The current TTM SG&A of TLIS is -$2.18 B
What is the all time high TTM SG&A for Talis Biomedical?
Talis Biomedical all-time high TTM selling, general & administrative expenses is $47.02 M
What is Talis Biomedical TTM SG&A year-on-year change?
Over the past year, TLIS TTM selling, general & administrative expenses has changed by -$2.21 B (-6830.75%)